Your browser doesn't support javascript.
loading
Association between glucose metabolism, the circadian cycle and hypoxia: Evaluation of the NPAS2 and Rev-Erb-α protein serum levels in obstructive sleep apnea patients - a pilot study.
Karuga, Filip Franciszek; Jaromirska, Julia; Sochal, Marcin; Bialasiewicz, Piotr; Gabryelska, Agata.
Afiliación
  • Karuga FF; Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Poland.
  • Jaromirska J; Department of Gynecology, Oncological Gynecology and Treatment of Endometriosis, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
  • Sochal M; Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Poland.
  • Bialasiewicz P; Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Poland.
  • Gabryelska A; Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Poland.
Dent Med Probl ; 61(3): 465-469, 2024.
Article en En | MEDLINE | ID: mdl-38804230
ABSTRACT

BACKGROUND:

Obstructive sleep apnea (OSA) is one of the risk factors for diabetes mellitus type 2 (DM2). As OSA is associated with the disruption of the circadian rhythm, it affects circadian clock proteins, including neuronal PAS domain protein 2 (NPAS2) and nuclear receptor subfamily 1 group D member 1 (Rev-Erb-α). These proteins have been shown to be related to metabolic abnormalities, i.a., insulin resistance.

OBJECTIVES:

The present pilot study aimed to investigate the NPAS2 and Rev-Erb-α protein serum levels in the groups of patients with severe OSA and severe OSA+DM2 in comparison with healthy controls, taking into account correlations with polysomnography (PSG) parameters (e.g., oxygen saturation (SpO2) variables). MATERIAL AND

METHODS:

A total of 40 participants were included in the study. They were split into 3 groups as follows the OSA group (n = 17; apnea-hypopnea index (AHI) >30, no DM2); the OSA+DM2 group (n = 7; AHI > 30 and DM2); and the control group (n = 16; AHI < 5, no DM2). All participants underwent a nocturnal PSG examination and had their blood collected the following morning. The serum levels of NPAS2 and Rev-Erb-α proteins were assessed using the enzyme-linked immunosorbent assay (ELISA).

RESULTS:

The mean NPAS2 protein level was significantly lower in the OSA group as compared to healthy individuals (p = 0.017). Additionally, the OSA group presented with lower NPAS2 protein levels as compared to the OSA+DM2 group, but only a tendency was observed (p = 0.094). No differences in the Rev-Erb-α protein concentration were noticed. Furthermore, a negative correlation between AHI during rapid eye movement (REM) sleep and the NPAS2 protein serum level was observed (r = -0.478; p = 0.002).

CONCLUSIONS:

Serum NPAS2 protein might be involved in metabolic dysregulation present among OSA patients, while the mechanism itself may be associated with REM sleep.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ritmo Circadiano / Apnea Obstructiva del Sueño / Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico / Miembro 1 del Grupo D de la Subfamilia 1 de Receptores Nucleares / Hipoxia / Proteínas del Tejido Nervioso Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Dent Med Probl Año: 2024 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ritmo Circadiano / Apnea Obstructiva del Sueño / Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico / Miembro 1 del Grupo D de la Subfamilia 1 de Receptores Nucleares / Hipoxia / Proteínas del Tejido Nervioso Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Dent Med Probl Año: 2024 Tipo del documento: Article País de afiliación: Polonia